{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:01:22Z","timestamp":1790474482893,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.cardfail.2016.07.429","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T01:01:46Z","timestamp":1468717306000},"page":"72-80","source":"Crossref","is-referenced-by-count":31,"title":["Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment"],"prefix":"10.1016","volume":"23","author":[{"given":"Stephanie J.","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Sucharov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"van Dusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nunley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Wickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Karimpur-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-7750","authenticated-orcid":false,"given":"Brian L.","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley D.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen C.","family":"Sucharov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2016.07.429_bib0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","article-title":"Enalapril in infants with single ventricle: results of a multicenter randomized trial","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2009.11.059","article-title":"The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy","volume":"55","author":"Kantor","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0025","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/eurheartj\/ehs229","article-title":"Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy","volume":"35","author":"Miyamoto","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2014.02.030","article-title":"Gene expression and beta-adrenergic signaling are altered in hypoplastic left heart syndrome","volume":"33","author":"Miyamoto","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCHEARTFAILURE.114.001218","article-title":"Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy","volume":"8","author":"Nakano","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpeds.2016.04.009","article-title":"Myocardial response to milrinone in single right ventricle heart disease","volume":"174","author":"Nakano","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0050","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/01.CIR.98.13.1329","article-title":"Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway","volume":"98","author":"Communal","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0055","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0735-1097(00)00913-X","article-title":"Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure","volume":"36","author":"Sabbah","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cardfail.2005.11.001","article-title":"Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure","volume":"12","author":"Price","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.healun.2007.02.004","article-title":"Home inotropic therapy in children","volume":"26","author":"Berg","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0070","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0075","doi-asserted-by":"crossref","first-page":"40938","DOI":"10.1074\/jbc.M314238200","article-title":"Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration","volume":"279","author":"Iwatsubo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0080","doi-asserted-by":"crossref","first-page":"H240","DOI":"10.1152\/ajpheart.00630.2014","article-title":"Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart","volume":"308","author":"Zhao","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0085","doi-asserted-by":"crossref","first-page":"13553","DOI":"10.1016\/S0021-9258(18)42247-8","article-title":"Isolation and characterization of a novel cardiac adenylylcyclase cDNA","volume":"267","author":"Ishikawa","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2015.01.149","article-title":"Coupling of beta1-adrenergic receptor to type 5 adenylyl cyclase and its physiological relevance in cardiac myocytes","volume":"458","author":"Tsunematsu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0095","doi-asserted-by":"crossref","first-page":"H1776","DOI":"10.1152\/ajpheart.00050.2009","article-title":"Adenylyl cyclase type 5 protein expression during cardiac development and stress","volume":"297","author":"Hu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCRESAHA.109.216127","article-title":"Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels","volume":"107","author":"Nichols","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.107.730069","article-title":"Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling","volume":"117","author":"Tang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0110","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2009.11.066","article-title":"Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice","volume":"55","author":"Tang","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yjmcc.2013.04.005","article-title":"Adenylyl cyclase 6 deletion increases mortality during sustained beta-adrenergic receptor stimulation","volume":"60","author":"Tang","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pharmthera.2005.04.006","article-title":"Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling","volume":"108","author":"Zheng","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.yjmcc.2013.07.016","article-title":"Deletion of the beta2-adrenergic receptor prevents the development of cardiomyopathy in mice","volume":"63","author":"Fajardo","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"Pt 24","key":"10.1016\/j.cardfail.2016.07.429_bib0130","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1113\/jphysiol.2014.282996","article-title":"Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by beta2-adrenoceptor stimulation","volume":"592","author":"Ohnuki","year":"2014","journal-title":"J Physiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1254\/jphs.12195FP","article-title":"Effects of chronic Akt\/mTOR inhibition by rapamycin on mechanical overload-induced hypertrophy and myosin heavy chain transition in masseter muscle","volume":"122","author":"Umeki","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0140","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/0022-2828(95)90002-0","article-title":"Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity","volume":"27","author":"Espinasse","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.RES.74.4.596","article-title":"Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle","volume":"74","author":"Tobise","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/FJC.0b013e31821bc3f0","article-title":"A kinase-anchoring proteins and adenylyl cyclase in cardiovascular physiology and pathology","volume":"58","author":"Efendiev","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0155","doi-asserted-by":"crossref","first-page":"29815","DOI":"10.1074\/jbc.M112.380568","article-title":"The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart","volume":"287","author":"Li","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0160","doi-asserted-by":"crossref","first-page":"32749","DOI":"10.1074\/jbc.M703173200","article-title":"Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes","volume":"282","author":"Vandeput","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.lfs.2011.11.016","article-title":"Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig","volume":"90","author":"Johnson","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0170","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/j.1742-4658.2007.06001.x","article-title":"Characterization of inhibitors of phosphodiesterase 1C on a human cellular system","volume":"274","author":"Dunkern","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000087541.15600.2B","article-title":"Cyclic GMP phosphodiesterases and regulation of smooth muscle function","volume":"93","author":"Rybalkin","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardiores.2007.02.031","article-title":"Phosphodiesterase regulation of nitric oxide signaling","volume":"75","author":"Kass","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0185","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.healun.2012.07.005","article-title":"Regulation of cyclic adenosine monophosphate release by selective beta2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support","volume":"31","author":"Kassner","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0195","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCULATIONAHA.108.822072","article-title":"Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice","volume":"119","author":"Pokreisz","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility","volume":"116","author":"Nagendran","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0205","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1096\/fj.00-0538com","article-title":"Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure","volume":"15","author":"Senzaki","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0210","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2012.4824","article-title":"Nitric oxide synthases in heart failure","volume":"18","author":"Carnicer","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0215","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/eurheartj\/ehr445","article-title":"Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I","volume":"34","author":"Frantz","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0220","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2010.08.612","article-title":"Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5","volume":"56","author":"Zhang","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0225","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0235","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ahj.2015.03.018","article-title":"PDE 5 inhibition with udenafil improves left ventricular systolic\/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; a 12-week, randomized, double-blind, placebo-controlled trial","volume":"169","author":"Kim","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0240","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0245","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","article-title":"Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial","volume":"123","author":"Goldberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0250","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00246-012-0196-9","article-title":"Impact of sildenafil on echocardiographic indices of myocardial performance after the Fontan operation","volume":"33","author":"Goldberg","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0255","doi-asserted-by":"crossref","first-page":"33824","DOI":"10.1074\/jbc.M109.020388","article-title":"Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes","volume":"284","author":"De Arcangelis","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0260","doi-asserted-by":"crossref","first-page":"23540","DOI":"10.1074\/jbc.M109.030072","article-title":"An adenylyl cyclase\u2013mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes","volume":"284","author":"Kapiloff","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0270","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1006\/jmcc.1997.0544","article-title":"Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin\u2013preconditioned rat heart","volume":"29","author":"Kostic","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00395-010-0138-8","article-title":"Conserved expression and functions of PDE4 in rodent and human heart","volume":"106","author":"Richter","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cardfail.2016.07.429_bib0280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0303-7207(00)00322-1","article-title":"Expression of multiple adenylyl cyclase isoforms in human and dog thyroid","volume":"170","author":"Vanvooren","year":"2000","journal-title":"Mol Cell Endocrinol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916416310387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916416310387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T05:17:12Z","timestamp":1656825432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916416310387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1071916416310387"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2016.07.429","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}